Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study.

<h4>Introduction</h4>Given clinicians' frequent concerns about unfavourable outcomes, Intensive Care Unit (ICU) triage decisions in acutely ill cancer patients can be difficult, as clinicians may have doubts about the appropriateness of an ICU admission. To aid to this decision maki...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Esther N van der Zee, Lianne M Noordhuis, Jelle L Epker, Nikki van Leeuwen, Bas P L Wijnhoven, Dominique D Benoit, Jan Bakker, Erwin J O Kompanje
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/43f59fd92f354f328529d856331a7c99
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:43f59fd92f354f328529d856331a7c99
record_format dspace
spelling oai:doaj.org-article:43f59fd92f354f328529d856331a7c992021-12-02T20:07:09ZAssessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study.1932-620310.1371/journal.pone.0252771https://doaj.org/article/43f59fd92f354f328529d856331a7c992021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0252771https://doaj.org/toc/1932-6203<h4>Introduction</h4>Given clinicians' frequent concerns about unfavourable outcomes, Intensive Care Unit (ICU) triage decisions in acutely ill cancer patients can be difficult, as clinicians may have doubts about the appropriateness of an ICU admission. To aid to this decision making, we studied the survival and performance status of cancer patients 2 years following an unplanned ICU admission.<h4>Materials and methods</h4>This was a retrospective cohort study in a large tertiary referral university hospital in the Netherlands. We categorized all adult patients with an unplanned ICU admission in 2017 into two groups: patients with or without an active malignancy. Descriptive statistics, Pearson's Chi-square tests and the Mann-Whitney U tests were used to evaluate the primary objective 2-year mortality and performance status. A good performance status was defined as ECOG performance status 0 (fully active) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out light work). A multivariable binary logistic regression analysis was used to identify factors associated with 2-year mortality within cancer patients.<h4>Results</h4>Of the 1046 unplanned ICU admissions, 125 (12%) patients had cancer. The 2-year mortality in patients with cancer was significantly higher than in patients without cancer (72% and 42.5%, P <0.001). The median performance status at 2 years in cancer patients was 1 (IQR 0-2). Only an ECOG performance status of 2 (OR 8.94; 95% CI 1.21-65.89) was independently associated with 2-year mortality.<h4>Conclusions</h4>In our study, the majority of the survivors have a good performance status 2 years after ICU admission. However, at that point, three-quarter of these cancer patients had died, and mortality in cancer patients was significantly higher than in patients without cancer. ICU admission decisions in acutely ill cancer patients should be based on performance status, severity of illness and long-term prognosis, and this should be communicated in the shared decision making. An ICU admission decision should not solely be based on the presence of a malignancy.Esther N van der ZeeLianne M NoordhuisJelle L EpkerNikki van LeeuwenBas P L WijnhovenDominique D BenoitJan BakkerErwin J O KompanjePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0252771 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Esther N van der Zee
Lianne M Noordhuis
Jelle L Epker
Nikki van Leeuwen
Bas P L Wijnhoven
Dominique D Benoit
Jan Bakker
Erwin J O Kompanje
Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study.
description <h4>Introduction</h4>Given clinicians' frequent concerns about unfavourable outcomes, Intensive Care Unit (ICU) triage decisions in acutely ill cancer patients can be difficult, as clinicians may have doubts about the appropriateness of an ICU admission. To aid to this decision making, we studied the survival and performance status of cancer patients 2 years following an unplanned ICU admission.<h4>Materials and methods</h4>This was a retrospective cohort study in a large tertiary referral university hospital in the Netherlands. We categorized all adult patients with an unplanned ICU admission in 2017 into two groups: patients with or without an active malignancy. Descriptive statistics, Pearson's Chi-square tests and the Mann-Whitney U tests were used to evaluate the primary objective 2-year mortality and performance status. A good performance status was defined as ECOG performance status 0 (fully active) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out light work). A multivariable binary logistic regression analysis was used to identify factors associated with 2-year mortality within cancer patients.<h4>Results</h4>Of the 1046 unplanned ICU admissions, 125 (12%) patients had cancer. The 2-year mortality in patients with cancer was significantly higher than in patients without cancer (72% and 42.5%, P <0.001). The median performance status at 2 years in cancer patients was 1 (IQR 0-2). Only an ECOG performance status of 2 (OR 8.94; 95% CI 1.21-65.89) was independently associated with 2-year mortality.<h4>Conclusions</h4>In our study, the majority of the survivors have a good performance status 2 years after ICU admission. However, at that point, three-quarter of these cancer patients had died, and mortality in cancer patients was significantly higher than in patients without cancer. ICU admission decisions in acutely ill cancer patients should be based on performance status, severity of illness and long-term prognosis, and this should be communicated in the shared decision making. An ICU admission decision should not solely be based on the presence of a malignancy.
format article
author Esther N van der Zee
Lianne M Noordhuis
Jelle L Epker
Nikki van Leeuwen
Bas P L Wijnhoven
Dominique D Benoit
Jan Bakker
Erwin J O Kompanje
author_facet Esther N van der Zee
Lianne M Noordhuis
Jelle L Epker
Nikki van Leeuwen
Bas P L Wijnhoven
Dominique D Benoit
Jan Bakker
Erwin J O Kompanje
author_sort Esther N van der Zee
title Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study.
title_short Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study.
title_full Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study.
title_fullStr Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study.
title_full_unstemmed Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study.
title_sort assessment of mortality and performance status in critically ill cancer patients: a retrospective cohort study.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/43f59fd92f354f328529d856331a7c99
work_keys_str_mv AT esthernvanderzee assessmentofmortalityandperformancestatusincriticallyillcancerpatientsaretrospectivecohortstudy
AT liannemnoordhuis assessmentofmortalityandperformancestatusincriticallyillcancerpatientsaretrospectivecohortstudy
AT jellelepker assessmentofmortalityandperformancestatusincriticallyillcancerpatientsaretrospectivecohortstudy
AT nikkivanleeuwen assessmentofmortalityandperformancestatusincriticallyillcancerpatientsaretrospectivecohortstudy
AT basplwijnhoven assessmentofmortalityandperformancestatusincriticallyillcancerpatientsaretrospectivecohortstudy
AT dominiquedbenoit assessmentofmortalityandperformancestatusincriticallyillcancerpatientsaretrospectivecohortstudy
AT janbakker assessmentofmortalityandperformancestatusincriticallyillcancerpatientsaretrospectivecohortstudy
AT erwinjokompanje assessmentofmortalityandperformancestatusincriticallyillcancerpatientsaretrospectivecohortstudy
_version_ 1718375298690449408